ASLAN Pharmaceuticals

Investor Relations

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-044147.pdf
0001564590-20-044147.rtf
0001564590-20-044147.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-043862.pdf
0001564590-20-043862.rtf
0001564590-20-043862.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-042589.pdf
0001564590-20-042589.rtf
0001564590-20-042589.xls
F-6EF

F-6EF
Other
 View HTML
0001193805-20-001115.pdf
0001193805-20-001115.rtf
0001193805-20-001115.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-040998.pdf
0001564590-20-040998.rtf
0001564590-20-040998.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-035281.pdf
0001564590-20-035281.rtf
0001564590-20-035281.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-032528.pdf
0001564590-20-032528.rtf
0001564590-20-032528.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-032226.pdf
0001564590-20-032226.rtf
0001564590-20-032226.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-029229.pdf
0001564590-20-029229.rtf
0001564590-20-029229.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001193125-20-164689.pdf
0001193125-20-164689.rtf
0001193125-20-164689.xls